NCT06435585Recruiting
Responders and Non-responders in the Management of Heart Failure - Significance of Genetic Influence and Identification of Novel Informative Biomarkers
Source: ClinicalTrials.gov · Last updated 10 Aug 2026
Brief summary (registry, in English)
A biobank within the Swedish national heart failure quality registry SwedeHF.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 5000 (estimated)
- First submitted
- 20 May 2024
- Start date
- 17 Feb 2021
- Primary completion date
- 31 Dec 2030
- Lead sponsor
- Karolinska University Hospital
- Diseases
- Heart failure
- NCT number
- NCT06435585
What you commit to
- Study type: Observational
- Planned participants: 5000
- From 17 Feb 2021 to the primary completion date, 31 Dec 2030
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Plasma donation within 1 month of enrolment or any blood donation/blood loss \>500 mL during the 3 months prior to enrolment
- Previous allogeneic bone marrow transplant (genetics)
Other illness
- In the opinion of the investigator, condition/s that may either put the patient at risk on participation or influence the results or the patient's ability to participate in the study.
Who the study is looking for
- Written informed consent
- Heart failure defined by symptoms and signs of heart failure as judged by the local investigator
- Registered in SwedeHF
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Karolinska University Hospital Coordinator of this site? Confirm its status | Stockholm | Sweden | Recruiting |
Related publications
- An integrated Biobank in the Swedish Heart Failure Registry-clinomics, proteomics, transcriptomics and genomics.ESC Heart Fail · 2026 · PMID 41961636
This page is information, not medical advice. Discuss any trial with your doctor.